Alterity Therapeutics Ltd. (AU:ATH) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alterity Therapeutics, a company focused on developing treatments for neurodegenerative diseases, has announced their CEO David Stamler will present at the MST Access ‘Hidden Gems in Life Sciences’ webinar. The event, aimed at investors and analysts, is set for 13th June 2024 in Australia and will be accessible via webcast with an interactive Q&A session. A recording will be made available on the company’s website following the webinar.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.